Category: Diversified Tech

Diversified Tech

SS&C Technologies Report Healthy Fourth-Quarter Results

SS&C reported healthy fourth-quarter results that were roughly in line with expectations on the top line but above expectations on the bottom line. The company delivered revenue of $182.5 million (growth of 6.3% year-over-year), slightly below consensus at $182.6 million, and non-GAAP EPS of $0.53, which was a penny ahead of the Street ($0.52). The software-enabled services and software license segments continue to benefit from … Continue reading SS&C Technologies Report Healthy Fourth-Quarter Results

Adam Keintzel
Diversified Tech, Tech IPO

Blount Conference Call Clarifies a Few Issues; 2014 Now Looks Like a Transition Year

On Monday, February 10, Blount issued a broad press release lowering its 2013 guidance and offering 2014 guidance that was below the Street expectations. Management held a conference call Tuesday afternoon to explain the results and outlook. Other corporate information was offered as well, including new 2018 targets and an update on the company’s long-term supply agreement with Husqvarna (extended from 2015 to 2017). Blount … Continue reading Blount Conference Call Clarifies a Few Issues; 2014 Now Looks Like a Transition Year

Mark Doerr
Gilead Sciences GILD NASDAQ:GILD
BioTech, Diversified Tech

Broadsoft Expected to Report Strong Quarter; Sprint Bringing Credibility in Mobile

For fourth quarter 2013, BroadSoft should meet or beat consensus estimates. We expect a large chunk of deferred revenue to come off the balance sheet and billings to show significant improvement sequentially in virtually all areas license, subscription, and maintenance on easy comparisons with the exception of professional services, which rebounded sharply in the third quarter. With respect to the outlook, the swing factor in … Continue reading Broadsoft Expected to Report Strong Quarter; Sprint Bringing Credibility in Mobile

Chris Lewis
BioTech, Diversified Tech

Pacific Biosciences Posts Encouraging Quarterly Results

PacBio reported results that were in line with our expectations but slightly ahead of consensus. Revenue was $9.1 million, relative to our estimate of $9.8 million and consensus of $8.8 million, and loss per share was $0.26, relative to our estimate and consensus of loss per share of $0.28. The company booked orders for 9 PacBio RS systems in the quarter (versus our estimate of … Continue reading Pacific Biosciences Posts Encouraging Quarterly Results

Chris Lewis
Diversified Tech, news, Tech IPO

InterActiveCorp Set to Report Q4 Earnings

InterActiveCorp is set to report 4Q13 results tomorrow before the market opens. Shares have risen steadily following soft 3Q Search results as a company-wide reorganization in December sparked expectations of a pending Match.com spin-off. We do not currently anticipate a spin announcement tomorrow, the absence of which could drive shares lower despite extremely low fundamental expectations, particularly regarding Search. However, even using conservative assumptions with … Continue reading InterActiveCorp Set to Report Q4 Earnings

John Meady
Consumer Goods, Diversified Tech, Software

LivePerson, Inc. 3Q Results Make the Grade; Getting Nearer to the Turn

Last night, LivePerson Inc., (LPSN) reported stronger than expected 3Q earnings, beating our and the Street’s estimates for bookings, total revenue and non-GAAP EPS. For the next quarter and 2013, management is guiding largely in line with the consensus, though it is tightening the full year ranges for revenue and EPS. Though the company reported respectable results and valuation is reasonable (2.1x EV/2014E Revenue), we … Continue reading LivePerson, Inc. 3Q Results Make the Grade; Getting Nearer to the Turn

Mark DeFrance